Cannabis Adolescent Psychiatric Risk Data Study Insights
This cannabis adolescent psychiatric risk data study highlights new concerns about marijuana use in teens and its association with psychiatric conditions. The developing adolescent brain is particularly vulnerable to cannabis effects, increasing risks…
Impairment Testing Problem Cannabis: Challenges & Insights
This daily digest highlights the impairment testing problem cannabis presents in clinical and policy contexts. It also covers cognitive safety and end-of-life access issues. The focus on impairment testing problem cannabis is crucial for advancing…
Veterans Groups Urge Congress to Expand Psychedelic and Cannabis Access
Veterans cannabis psychedelic therapy access is increasingly recognized as vital for treatment-resistant PTSD. Veterans currently face risks seeking therapies outside the VA system. Expanding access would improve clinical supervision and continuity of…
Natural Neuroprotection: Exploring Non-Psychoactive Cannabinoids
Non-psychoactive cannabinoids neuroprotection offers promising avenues for neurological health. These compounds interact with the endocannabinoid system to modulate inflammation and oxidative stress. While preclinical data is strong, clinical evidence…
Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults
A recent study found no link between lifetime cannabis use cognitive decline in older adults. This evidence suggests that past cannabis exposure does not increase dementia risk. Clinicians can use these findings to inform patient discussions about…
End-of-Life Cannabis Access: Bridging Regulatory Gaps
End-of-life cannabis access remains a critical issue for patients and healthcare providers. This digest highlights regulatory gaps and hospital policies impacting terminally ill patients. Cognitive safety in older adults using cannabis is also examined…
Cognitive Safety in Older Adults: Latest Cannabis Insights
This digest highlights recent research on cognitive safety in older adults using cannabis, addressing dementia risk and clinical implications. It also covers advances in end-of-life cannabis access and ongoing regulatory friction. These insights provide…
2026 Cannabis Adolescent Brain Vulnerability and Risks
2026 cannabis adolescent brain vulnerability is a growing concern among researchers. Studies link teen cannabis use to increased psychiatric risks such as psychosis and depression. Understanding these risks is critical for public health and clinical…
Cannabis Cognitive Aging Older Adults: New Insights 2026
Recent studies on cannabis cognitive aging older adults provide reassuring data about cognitive decline risks. Evidence shows THC blood levels poorly predict driving impairment. Patient access remains a critical issue in the U.S. and U.K. healthcare…
The Wait is Over: Medical Cannabis Set to Roll Out in Alabama in April
Alabama medical cannabis program is moving forward with an official rollout planned for April. This program will expand patient access to cannabis therapeutics under state regulations. Physicians should prepare to integrate Alabama medical cannabis…
